The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
120913474 12091347 4 F 201511 20160614 20160218 20160725 EXP FR-TAKEDA-2016MPI001041 TAKEDA 62.00 YR F Y 40.00000 KG 20160725 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
120913474 12091347 1 PS VELCADE BORTEZOMIB 1 Subcutaneous 1.7 MG, UNK 21602 1.7 MG INJECTION
120913474 12091347 2 SS VELCADE BORTEZOMIB 1 Subcutaneous UNK 21602 INJECTION
120913474 12091347 3 SS DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) UNK 0
120913474 12091347 4 SS DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) 40 MG, UNK 0 40 MG
120913474 12091347 5 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 170 MG, UNK 0 170 MG
120913474 12091347 6 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) UNK 0
120913474 12091347 7 SS LEVACT BENDAMUSTINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 120 MG, UNK 0 120 MG
120913474 12091347 8 SS LEVACT BENDAMUSTINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) UNK 0
120913474 12091347 9 C POLARAMINE DEXCHLORPHENIRAMINE MALEATE 1 Intravenous (not otherwise specified) 5 MG, UNK 0 5 MG SOLUTION FOR INJECTION
120913474 12091347 10 C PARACETAMOL ACETAMINOPHEN 1 Intravenous (not otherwise specified) 500 MG, UNK 0 500 MG
120913474 12091347 11 C ONDANSETRON ONDANSETRON 1 Intravenous (not otherwise specified) 8 MG, UNK 0 8 MG SOLUTION FOR INJECTION
120913474 12091347 12 C EMEND APREPITANT 1 Oral 125 MG, UNK 0 125 MG
120913474 12091347 13 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 60 MG, UNK 0 60 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
120913474 12091347 1 Mantle cell lymphoma stage IV
120913474 12091347 3 Mantle cell lymphoma
120913474 12091347 5 Mantle cell lymphoma stage IV
120913474 12091347 7 Mantle cell lymphoma
120913474 12091347 9 Hypersensitivity
120913474 12091347 10 Pain
120913474 12091347 11 Prophylaxis of nausea and vomiting
120913474 12091347 12 Prophylaxis of nausea and vomiting

Outcome of event

Event ID CASEID OUTC COD
120913474 12091347 OT
120913474 12091347 DE
120913474 12091347 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
120913474 12091347 Febrile bone marrow aplasia
120913474 12091347 Mantle cell lymphoma
120913474 12091347 Nausea
120913474 12091347 Off label use

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
120913474 12091347 1 20151110 20151121 0
120913474 12091347 2 20151218 0
120913474 12091347 4 20151110 20151111 0
120913474 12091347 5 20151110 20151111 0
120913474 12091347 6 20151218 0
120913474 12091347 7 20151111 20151112 0
120913474 12091347 9 20151110 20151111 0
120913474 12091347 10 20151110 20151111 0
120913474 12091347 11 20151110 20151111 0
120913474 12091347 12 20151110 20151113 0
120913474 12091347 13 20151110 20151111 0